TARAH WRIGHT: Open Payments
NPI 1710453121 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 96 payments from 16 companies in 2025. Trend: 2023 $267 · 2024 $1,546 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $338 |
| Otsuka America Pharmaceutical, Inc. | 16 | $329 |
| ABBVIE INC. | 17 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $118 |
| Biogen, Inc. | 1 | $106 |
| Lundbeck LLC | 5 | $92 |
| Supernus Pharmaceuticals, Inc. | 6 | $90 |
| Neos Therapeutics, LP | 5 | $87 |
| Axsome Therapeutics, Inc. | 6 | $86 |
| Alkermes, Inc. | 4 | $78 |
Products named: REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX, ZURZUVAE, Qelbree, Adzenys XR-ODT, Auvelity.
Industry payments across NJ — which companies pay providers there.
